BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kornum BR. Narcolepsy type 1: what have we learned from immunology? Sleep 2020;43:zsaa055. [DOI: 10.1093/sleep/zsaa055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Yüceer H, Gezen Ak D, Benbir Şenel G, Dursun E, Yılmaz V, Karadeniz D, Tüzün E, Küçükali Cİ. Classical complement pathway factor alterations in narcolepsy. Acta Neuropsychiatr 2022;:1-8. [PMID: 35034679 DOI: 10.1017/neu.2021.42] [Reference Citation Analysis]
2 Holm A, Possovre ML, Bandarabadi M, Moseholm KF, Justinussen JL, Bozic I, Lemcke R, Arribat Y, Amati F, Silahtaroglu A, Juventin M, Adamantidis A, Tafti M, Kornum BR. The evolutionarily conserved miRNA-137 targets the neuropeptide hypocretin/orexin and modulates the wake to sleep ratio. Proc Natl Acad Sci U S A 2022;119:e2112225119. [PMID: 35452310 DOI: 10.1073/pnas.2112225119] [Reference Citation Analysis]
3 Berteotti C, Lo Martire V, Alvente S, Bastianini S, Bombardi C, Matteoli G, Ohtsu H, Lin JS, Silvani A, Zoccoli G. Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice. Front Neurosci 2021;15:660518. [PMID: 34093114 DOI: 10.3389/fnins.2021.660518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Giannoccaro MP, Liguori R, Plazzi G, Pizza F. Reviewing the Clinical Implications of Treating Narcolepsy as an Autoimmune Disorder. Nat Sci Sleep 2021;13:557-77. [PMID: 34007229 DOI: 10.2147/NSS.S275931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Lecomte A, Barateau L, Pereira P, Paulin L, Auvinen P, Scheperjans F, Dauvilliers Y. Gut microbiota composition is associated with narcolepsy type 1. Neurol Neuroimmunol Neuroinflamm 2020;7:e896. [PMID: 33037102 DOI: 10.1212/NXI.0000000000000896] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Viste R, Lie BA, Viken MK, Rootwelt T, Knudsen-Heier S, Kornum BR. Narcolepsy type 1 patients have lower levels of effector memory CD4+ T cells compared to their siblings when controlling for H1N1-(Pandemrix™)-vaccination and HLA DQB1∗06:02 status. Sleep Med 2021;85:271-9. [PMID: 34388506 DOI: 10.1016/j.sleep.2021.07.024] [Reference Citation Analysis]
7 Silvani A, Vandi S, Pizza F, Antelmi E, Ferri R, Plazzi G. Combining information on nocturnal rapid eye movement sleep latency and atonia to facilitate diagnosis of pediatric narcolepsy type 1. Sleep 2021;44:zsaa203. [PMID: 33035342 DOI: 10.1093/sleep/zsaa203] [Reference Citation Analysis]
8 Vellieux G, Frija-Masson J, Rouvel-Tallec A, Drouot X, d'Ortho MP. Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report. Nat Sci Sleep 2021;13:1669-73. [PMID: 34594143 DOI: 10.2147/NSS.S311283] [Reference Citation Analysis]
9 Vringer M, Kornum BR. Emerging therapeutic targets for narcolepsy. Expert Opin Ther Targets 2021;:1-14. [PMID: 34402358 DOI: 10.1080/14728222.2021.1969361] [Reference Citation Analysis]
10 Alvente S, Berteotti C, Bastianini S, Lo Martire V, Matteoli G, Silvani A, Zoccoli G. Autonomic mechanisms of blood pressure alterations during sleep in orexin/hypocretin-deficient narcoleptic mice. Sleep 2021;44:zsab022. [PMID: 33517440 DOI: 10.1093/sleep/zsab022] [Reference Citation Analysis]